Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
This study wants to learn what patients and healthcare professionals think about current treatments for a specific type of lung cancer called non-small cell lung cancer (NSCLC) that can be removed by surgery. Researchers want to understand their opinions and preferences regarding different treatment choices. This information helps us better tailor care to what matters most to patients and doctors. Participants must be 18 or older and live in the US, Germany, or Japan. Patients involved will have a diagnosed resectable NSCLC. Doctors taking part must specialise in lung cancer and have treated several new patients recently. The study involves sharing thoughts and experiences, not receiving new treatments.
At a glance
What is this study about?
This research study aims to understand what patients and their doctors think and feel about the different treatment options available for a specific type of lung cancer. This lung cancer is called non-small cell lung cancer, and importantly, it's the kind that doctors believe can be removed with an operation. The study isn't about testing new medicines or treatments; instead, it's focused on gathering opinions about existing treatments that are already approved and in use.
The idea is to get a clear picture of what's important to patients when they're making decisions about their treatment. For example, some people might value a treatment with fewer side effects, while others might prefer a treatment that offers the best chance of preventing the cancer from coming back. Similarly, the study also asks medical professionals – like lung cancer specialists, surgeons, and pathologists – what guides their choices and recommendations for their patients.
By bringing together these different perspectives, researchers hope to gain valuable insights. This information can help develop better ways to talk about treatment options, make sure patients feel well-informed, and ultimately, improve how care is given for people with this type of lung cancer. It helps doctors and healthcare systems understand what really matters in people's treatment journeys.
Key takeaways
- This study gathers opinions, not new treatments.
- It focuses on a specific type of lung cancer that can be surgically removed.
- Both patients and doctors can share what they think about treatments.
- Your input could help improve care for others in the future.
- Participation involves an interview, likely online, and is a one-time commitment.
Who may be eligible?
To take part in this study, you might be eligible if you are a patient, or a healthcare professional dealing with lung cancer.
If you are a patient, you need to be 18 years old or older and live in the United States, Germany, or Japan. You must also be able to read, speak, and understand English, German, or Japanese. Importantly, you would need to have been diagnosed with a type of non-small cell lung cancer (NSCLC) that doctors believe can be removed by surgery. This means your cancer would be classed as Stage II to Stage IIIB.
If you are a healthcare professional, you also need to live in the United States, Germany, or Japan. You should be a doctor who treats lung cancer and specialise in areas like oncology (cancer treatment), pneumonology (lung diseases), or thoracic surgery (chest surgery). You would also need to have treated at least three new patients with this specific type of NSCLC in the last year.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you live in the US, Germany, or Japan?
- Can you read and speak English, German, or Japanese fluently?
- Have you been diagnosed with non-small cell lung cancer (NSCLC) that's considered 'resectable' (can be removed by surgery), in stages II to IIIB?
- Are you comfortable with an interview, possibly audio-recorded, to share your opinions?
What does participation involve?
If you decide to take part in this study, you won't be given any new medications or treatments. Instead, your involvement will be about sharing your thoughts and experiences. This will likely involve answering questions in an interview, which could be online. For patients, this interview focuses on your views regarding treatments for your lung cancer. For doctors, it's about your professional opinions and experiences in treating patients with this cancer.
Some interviews may be audio-recorded, so you would need to be comfortable with that. There are no follow-up appointments after the interview, and the entire process of sharing your views is expected to be a single, short commitment. The study focuses purely on collecting opinions, not on your medical care.
Potential risks and benefits
Locations (1)
- EvideraVerified postcodeLondon, United Kingdom· Recruiting
Common questions
What kind of lung cancer is this study about?
It's about non-small cell lung cancer (NSCLC) that doctors believe can be removed with surgery.
Will I receive new treatment if I join?
No, this study only gathers opinions about already approved treatments, it does not offer new medicines or therapies.
Who can take part in this study?
Patients over 18 with specific lung cancer stage (II-IIIB) or doctors who treat this cancer, living in the US, Germany, or Japan.
What will I have to do if I participate?
You will share your thoughts and preferences in an online interview. Some interviews might be audio-recorded.
Can I change my mind and leave the study?
Yes, you can leave the study at any time without it affecting your medical care.
How to find out more
BMS Study Connect Contact Center www.BMSStudyConnect.com
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.